Posts

Biopharma Bites: 白宮AI挑戰、Mentari新資金、Royalty Pharma與Neurimmune交易

on

Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3

on

Ligand to Acquire XOMA Royalty for $739 Million, Accelerating Profit Growth

on

Revolution Medicines Secures $2B Funding from Royalty Pharma for RAS Cancer Drugs as Biotech Sector Heats Up

on

Zenas BioPharma Secures $300M Royalty Deal for Obexelimab FDA Approvals

on

Royalty Pharma Buys $885M Imdelltra Royalty Stake from BeOne

on

Royalty Pharma Commits $2 Billion to Revolution Medicines for RAS Cancer Drug Development

on

Biogen Secures $250 Million R&D Funding from Royalty Pharma for Lupus Drug Litifilimab

on

Royalty Pharma Invests $250M in Biogen's Late-Stage Lupus Treatment

on